Segantii Capital Management LTD Bei Gene, Ltd. Transaction History

Segantii Capital Management LTD

  • $807 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022
SELL
$146.52 - $269.56 $6.71 Million - $12.3 Million
-45,813 Closed
0 $0
Q4 2021

Jan 21, 2022
BUY
$248.56 - $389.34 $11.4 Million - $17.8 Million
45,813 New
45,813 $12.3 Million
Q1 2021

May 11, 2021
SELL
$260.64 - $382.12 $1.7 Million - $2.5 Million
-6,531 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$221.31 - $316.61 $1.45 Million - $2.07 Million
6,531 New
6,531 $1.72 Million

Others Institutions Holding BGNE

# of Institutions
252
Shares Held
45.3M
Call Options Held
292K
Put Options Held
119K
View Full List

About BeiGene, Ltd.

BGNE Quotes by TradingView
  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.7B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Segantii Capital Management LTD Portfolio

Follow Segantii Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Segantii Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email